Homepage
Medication Guide
How Effective is Fostemsavir in Treatment?
Fostemsavir is a novel antiretroviral drug specifically designed for the treatment of adult patients with multiply drug-resistant HIV-1 infection. As an HIV-1 gp120-directed attachment inhibitor, it i...
511
Wednesday, September 17th, 2025, 14:42
What Are the Side Effects of Fostemsavir?
Fostemsavir is an HIV-1 gp120-directed attachment inhibitor, indicated for adult patients with multiply drug-resistant HIV-1 infection. As part of combination antiretroviral therapy, its efficacy and ...
504
Wednesday, September 17th, 2025, 14:38
How to Use Fostemsavir
Fostemsavir is an HIV-1 gp120-directed attachment inhibitor. It is indicated for use in adult patients with multiply drug-resistant HIV-1 infection, in combination with other antiretroviral agents.How...
504
Wednesday, September 17th, 2025, 14:33
Indications for Aduhelm (Aducanumab)
Aduhelm (Aducanumab) is the first biological product targeting the pathological mechanism of Alzheimer's disease (AD) to receive accelerated approval from the U.S. FDA in 2021. It exerts its effec...
509
Tuesday, September 16th, 2025, 16:43
How Effective is Aduhelm (Aducanumab) in Treatment?
As the first FDA-approved breakthrough therapy targeting amyloid-beta, Aduhelm (Aducanumab) provides a new treatment option for patients with Alzheimer's disease.How Effective is Aduhelm (Aducanum...
505
Tuesday, September 16th, 2025, 16:36
What Are the Side Effects of Aduhelm (Aducanumab)?
Aduhelm (Aducanumab) is the first monoclonal antibody drug targeting beta-amyloid plaques in Alzheimer's disease to receive accelerated approval from the U.S. FDA. It is indicated for patients wit...
503
Tuesday, September 16th, 2025, 16:32
Indications for Talquetamab
Talquetamab is a bispecific T-cell engager targeting GPRC5D and CD3. It received accelerated approval from the U.S. FDA in 2023 for the treatment of relapsed or refractory multiple myeloma.Indications...
504
Tuesday, September 16th, 2025, 16:29
How to Administer Talquetamab
Talquetamab is a CD3 T-cell bispecific antibody targeting GPRC5D, indicated for the treatment of relapsed or refractory multiple myeloma. As a novel immunotherapy, its administration methods and preca...
505
Tuesday, September 16th, 2025, 16:27
Precautions for the Administration of Talquetamab
Talquetamab is a GPRC5D/CD3 bispecific antibody approved by the U.S. FDA in 2023 for the treatment of relapsed or refractory multiple myeloma.Precautions for the Administration of TalquetamabConfirmat...
505
Tuesday, September 16th, 2025, 16:24
How to Use Talquetamab
Talquetamab is a CD3 T-cell bispecific antibody targeting GPRC5D, indicated for the treatment of relapsed or refractory multiple myeloma. As a novel immunotherapy, its administration methods and preca...
510
Tuesday, September 16th, 2025, 16:22
115 / 207
2069 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved